Time limits apply in Kansas. Find out if you still qualify.
Start Your Free Review
Answer 2-3 quick questions to review your potential case.
Verified against court records, regulatory records, and peer-reviewed research.
Last reviewed against primary sources: June 11, 2026
Statute of Limitations
Kansas: 2 years from discovery (K.S.A. § 60-513)
2 years from BIA-ALCL diagnosis or discovery of BIOCELL injury connection
Where to File in Kansas
Kansas plaintiffs with Allergan BIOCELL claims file in MDL 2921 in the District of New Jersey. Kansas applies a 2-year personal injury statute under K.S.A. § 60-513 with the discovery rule. Wichita and the Kansas City metro area (covering both Kansas and Missouri) placed Allergan BIOCELL products during the 2005–2019 period. Kansas plaintiffs with BIA-ALCL diagnoses from 2024 onward are within the limitations window.
Exposure in Kansas
Source: FDA MAUDE Adverse Event Database
Source: Allergan/AbbVie; FDA Safety Communication